相关实验视频

Updated: Jun 13, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

819

Polygala fallax Hemsl 多糖通过通过AMPK修改脂质代谢来缓解酒精性脂肪性肝病

Rui Lv1, Houkang Cao1, Mingli Zhong1

  • 1Pharmacology Laboratory of Prevention and Treatment of High Incidence of Disease, Guilin Medical University, Guilin 541199, China.

International journal of biological macromolecules
|September 13, 2024
PubMed
概括

聚格拉 fallax Hemsl 多糖 (PFPs) 通过减少肝脏脂肪积累和改善肝功能来预防酒精性脂肪性肝病 (AFLD). PFPs激活AMPK通路,增强脂质代谢和抗氧化剂防御.

关键词:
这就是AMPKK.酒精性脂肪肝疾病是什么波利加拉法拉克斯 (Polygala fallax) 是赫姆斯的多糖类之一.

更多相关视频

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.9K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.9K

相关概念视频

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
167